Skip to main content
Journal ArticleOPEN ACCESS

A novel biomarker assay for cancer immunotherapy development based on myeloid derived supressor cells (MDSCs)

  • Hepburne-Scott H
Journal for ImmunoTherapy of Cancer (2013) 1(S1)
DOI: 10.1186/2051-1426-1-s1-p103
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Cite

CITATION STYLE

APA

Hepburne-Scott, H. (2013). A novel biomarker assay for cancer immunotherapy development based on myeloid derived supressor cells (MDSCs). Journal for ImmunoTherapy of Cancer, 1(S1). https://doi.org/10.1186/2051-1426-1-s1-p103

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free